butenafine hydrochloride, 101827-46-7

Articles:

PubMed:	Tinea nigra presenting speckled or "salt and pepper" pattern.
PubMed:	Influence of penetration enhancers and molecular weight in antifungals permeation through bovine hoof membranes and prediction of efficacy in human nails.
PubMed:	Efficacy of topical antifungals in the treatment of dermatophytosis: a mixed-treatment comparison meta-analysis involving 14 treatments.
PubMed:	Determination of butenafine hydrochloride in human plasma by liquid chromatography electrospray ionization-mass spectrometry following its topical administration in human subjects.
PubMed:	Stability-indicating LC assay for butenafine hydrochloride in creams using an experimental design for robustness evaluation and photodegradation kinetics study.
PubMed:	RP-HPLC method for simultaneous determination of butenafine hydrochloride and betamethasone dipropionate in a cream formulation.
PubMed:	A simple and rapid method to assess butenafine hydrochloride in skin samples and a comparative cutaneous retention study of two marketed formulations.
PubMed:	Simultaneous HPLC determination of butenafine hydrochloride and betamethasone in a cream formulation.
PubMed:	Butenafine and superficial mycoses: current status.
PubMed:	A Japanese case of tinea corporis caused by Arthroderma benhamiae.
PubMed:	Butenafine hydrochloride (Mentax) cream for the treatment of hyperkeratotic type tinea pedis and its transfer into the horny layer, with or without concomitant application of 20% urea ointment (Keratinamin).
PubMed:	Comparison of in vitro antifungal activities of topical antimycotics launched in 1990s in Japan.
PubMed:	Butenafine hydrochloride: for the treatment of interdigital tinea pedis.
PubMed:	Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream.
PubMed:	Management of toenail onychomycosis with 2% butenafine and 20% urea cream: a placebo-controlled, double-blind study.
PubMed:	A randomized trial to assess once-daily topical treatment of tinea corporis with butenafine, a new antifungal agent.
PubMed:	Butenafine 1% cream in the treatment of tinea cruris: a multicenter, vehicle-controlled, double-blind trial.
PubMed:	One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial.
PubMed:	Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream.
PubMed:	Two mechanisms of butenafine action in Candida albicans.
PubMed:	[Synthesis and antifungal activity of butenafine hydrochloride (KP-363), a new benzylamine antifungal agent].
PubMed:	Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental tinea pedis in guinea pigs.
PubMed:	Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental dermatophytosis in guinea pigs.